Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis

Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis

IntroductionMultiple sclerosis (MS) is a potentially disabling disease that damages the brain and spinal cord, inducing paralysis of the body. While MS has been known as a T-cell mediated disease, recent attention has been drawn to the involvement of B cells in its pathogenesis. Autoantibodies from...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, Yoe-Sik Bae
Format:	Artykuł
Język:	English
Wydane:	Frontiers Media S.A. 2023-06-01
Seria:	Frontiers in Immunology
Hasła przedmiotowe:	sphingosylphosphorylcholine plasma cells S1PR3 experimental autoimmune encephalomyelitis multiple sclerosis
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151511/full

Podobne zapisy

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
od: Michael Basler, i wsp.
Wydane: (2014-01-01)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
od: Leonie Stolz, i wsp.
Wydane: (2017-07-01)

Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
od: Pece Kocovski, i wsp.
Wydane: (2021-06-01)

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
od: Kaili Lu, i wsp.
Wydane: (2020-02-01)

Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
od: Jeong Hyo-Soon, i wsp.
Wydane: (2011-08-01)

Effect of Cordyceps sinensis on the Treatment of Experimental Autoimmune Encephalomyelitis: A Pilot Study on Mice Model
od: Shan-Shan Zhong, i wsp.
Wydane: (2017-01-01)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
od: Sofia P. das Neves, i wsp.
Wydane: (2018-10-01)

Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis
od: Zhaolan Hu, i wsp.
Wydane: (2018-07-01)

Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation
od: Thais Fernanda de Campos Fraga-Silva, i wsp.
Wydane: (2019-07-01)

Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
od: Ji-Youn Kim, i wsp.
Wydane: (2020-05-01)

Peptide immunotherapy in experimental autoimmune encephalomyelitis
od: Stephen M Anderton
Wydane: (2015-06-01)

From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis
od: Emma L Walton
Wydane: (2015-06-01)

Oligodendrocyte-specific Argonaute profiling identifies microRNAs associated with experimental autoimmune encephalomyelitis
od: Qin Ma, i wsp.
Wydane: (2020-10-01)

Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
od: Juan E. Tichauer, i wsp.
Wydane: (2023-06-01)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
od: Dhaiban S, i wsp.
Wydane: (2020-09-01)

Phenethyl Ester of Gallic Acid Ameliorates Experimental Autoimmune Encephalomyelitis
od: Goran Stegnjaić, i wsp.
Wydane: (2022-12-01)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
od: Ghareghani Majid, i wsp.
Wydane: (2021-05-01)

Effects of increased proliferation of human adipose tissue-derived mesenchymal stem cells by sphingosylphosphorylcholine on the survival of cryopreserved fat grafts
od: Bae Yong Chan, i wsp.
Wydane: (2018-01-01)

Oral Administration of Probiotic Enterococcus durans to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice
od: Seyed Abdollah Samani, i wsp.
Wydane: (2022-01-01)

Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis
od: Sienna S. Drake, i wsp.
Wydane: (2024-11-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
od: M. Moransard, i wsp.
Wydane: (2017-10-01)

Modulation of Ryanodine Receptors Activity Alters the Course of Experimental Autoimmune Encephalomyelitis in Mice
od: Natalia C. Osipchuk, i wsp.
Wydane: (2021-12-01)

Effect of Voluntary Training after the Induction of Experimental Autoimmune Encephalomyelitis on Some Myelin-Producing Proteins in Female C57BL/6 Mice
od: Yasaman Honarmandnasab, i wsp.
Wydane: (2021-02-01)

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
od: Alba Sánchez-Fernández, i wsp.
Wydane: (2022-02-01)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
od: Amy Lovett-Racke, i wsp.
Wydane: (2022-11-01)

Therapeutic effect of nucleoside analogs on experimental autoimmune encephalomyelitis in dark agouti rats
od: Stojkov Danijela, i wsp.
Wydane: (2006-01-01)

IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis
od: Jin Kyeong Choi, i wsp.
Wydane: (2017-10-01)

Amelioration of Experimental Autoimmune Encephalomyelitis in Alzheimer’s Disease Mouse Models: A Potential Role for Aβ
od: Changjie Shi, i wsp.
Wydane: (2022-03-01)

Treatment of Experimental Autoimmune Encephalomyelitis with an Inhibitor of Phosphodiesterase-8 (PDE8)
od: Chaitali P. Basole, i wsp.
Wydane: (2022-02-01)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
od: Marina Boziki, i wsp.
Wydane: (2023-01-01)

Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats
od: Gonçalo Castelo-Branco, i wsp.
Wydane: (2014-11-01)

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
od: Ulaş Ceylan, i wsp.
Wydane: (2021-05-01)

Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicryResearch in context
od: Xin Ma, i wsp.
Wydane: (2025-01-01)

Gestational Hypothyroxinemia Affects Its Offspring With a Reduced Suppressive Capacity Impairing the Outcome of the Experimental Autoimmune Encephalomyelitis
od: Henny Haensgen, i wsp.
Wydane: (2018-06-01)

Age related immune modulation of experimental autoimmune encephalomyelitis in PINK1 knockout mice
od: Davide Cossu, i wsp.
Wydane: (2022-11-01)

Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation
od: Hiroshi Horiuchi, i wsp.
Wydane: (2021-03-01)

Teriflunomide attenuates immunopathological changes in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
od: Garth E. Ringheim, i wsp.
Wydane: (2013-10-01)

Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
od: Sungmoo Hong, i wsp.
Wydane: (2024-12-01)

In Vivo Induction of Regulatory T Cells Via CTLA‐4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse
od: Gil‐Ran Kim, i wsp.
Wydane: (2021-07-01)

Oleanolic Acid Acetate Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis in Mice by Regulating Toll-Like Receptor 2 Signaling
od: Minju Kim, i wsp.
Wydane: (2020-09-01)